Megan Wise

USPTO Granted Patents = 4 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

3 out of 2,623

University of Pennsylvania

Inovio Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11883484 - Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates (2024-01-30),

2. 11845787 - DNA antibody constructs for use against HIV (2023-12-19),

3. 10925961 - Vaccines with CD40 ligand as an adjuvant (2021-02-23),

4. 10828363 - Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates (2020-11-10),

Title: The Innovative Journey of Megan Wise

Introduction: Megan Wise, a talented inventor based in Raleigh, NC, has been making waves in the world of technology with her groundbreaking creations.

Latest Patents: Megan Wise's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a background in biomedical engineering, Megan Wise has dedicated her career to developing innovative solutions to improve people's lives. She has received numerous awards for her contributions to the field of medical technology.

Collaborations: Megan Wise has collaborated with leading research institutions and universities to further her research and bring her inventions to the market. Her partnerships have been instrumental in pushing the boundaries of innovation.

Conclusion: Megan Wise's passion for innovation and commitment to excellence continue to drive her forward in her quest to create technologies that have a lasting impact on society. Her work serves as an inspiration to aspiring inventors around the world.

This text is generated by artificial intelligence and may not be accurate.